Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen Images
Generic Name: insulin glargine/lixisenatide
This medication has been identified as Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen. It is supplied by Sanofi.
Soliqua is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Soliqua 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Soliqua
- Generic Name
- insulin glargine/lixisenatide
- Strength
- 100 units/mL insulin glargine and 33 mcg/mL lixisenatide prefilled pen
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi
- National Drug Code (NDC)
- 00024-5761
More about Soliqua (insulin glargine / lixisenatide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
